Overview

PathMaker Neurosystems is opening up a new era of non-invasive treatment of ALS and other serious neurological disorders. Our vision is to make ALS a livable disease through non-invasive neuromodulation, and we are pioneering the restoration of damaged neural pathways.  Our proprietary technology is built upon the pioneering work of Prof. Zaghloul Ahmed (CUNY) and our scientific advisors. With offices in Boston and New York, we are rapidly moving  our clinical-stage programs forward to commercialization with a veteran team of medical device executives.